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Abstract. Many actin-binding proteins affect filament 
assembly in vitro and localize with actin in vivo, but 
how their molecular actions contribute to filament as- 
sembly in vivo is not understood well. We report here 
that capping protein (CP) and fimbrin are both impor- 
tant for actin filament assembly in vivo in Saccharomy- 
ces cerevisiae,  based on finding decreased actin filament 
assembly in CP and fimbrin mutants. We have also 
identified mutations in actin that enhance the CP phe- 
notype and find that those mutants also have decreased 
actin filament assembly in vivo. In vitro, actin purified 
from some of these mutants is defective in polymeriza- 
tion or binding fimbrin. These findings support the con- 
clusion that CP acts to stabilize actin filaments in vivo. 
This conclusion is particularly remarkable because it is 
the opposite of the conclusion drawn from recent stud- 
ies in Dictyostelium (Hug, C., P. Y. Jay, I. Reddy, J. G. 
McNally, P. C. Bridgman, E. L. Elson, and J. A. Coo- 
per. 1995. Cell 81:591-600). In addition, we find that 
the unpolymerized pool of actin in yeast is very small 
relative to that found in higher cells, which suggests 
that actin filament assembly is less dynamic in yeast 
than higher cells. 
I 
N Saccharomyces cerevisiae, actin is essential for viabil- 
ity (35),  and  important  for polarized secretion (28) 
and endocytosis (19). The functional state of actin is 
presumed to be a helical filament, assembled from mono- 
meric subunits.  The  assembly  and  activity of actin  fila- 
ments can be regulated in vitro by a large number of pro- 
teins  that  interact  with  actin.  We  wish  to  understand 
assembly of actin filaments in vivo and to achieve a molec- 
ular view of how actin-binding proteins function to control 
actin filament assembly. In vitro, monomers add to and 
leave  from  filaments  at  their  ends,  both  barbed  and 
pointed. Therefore, filament assembly in vivo can theoret- 
ically be controlled by actin-binding proteins that bind to 
monomers or filaments and inhibit, enhance, or bias this 
exchange reaction. 
In vitro, capping protein (CP) 1 binds to the barbed end 
of  actin  filaments,  which  inhibits  both  assembly  (actin 
monomer addition) and disassembly (actin monomer loss) 
of the filament (for review see 30). CP is found in all eu- 
karyotes, including S. cerevisiae, where the heterodimeric 
protein is encoded by the genes CAP1  and CAP2 (3, 4). 
CP colocalizes with filamentous actin in yeast and other 
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cells (3, 31,  32).  In developing muscle, the actin-binding 
activity of CP is necessary for proper assembly of the actin 
filaments of the sarcomere (34). In muscle, CP probably 
helps to determine the proper location and polarity of the 
actin filaments as well as to prevent their growth into adja- 
cent sarcomeres. In Dictyostelium, CP functions to limit or 
inhibit growth at barbed ends, and the level of CP deter- 
mines the level of actin filament assembly (15). 
One might imagine that mechanisms governing actin fil- 
ament assembly in yeast are very different from those that 
operate in striated muscle, Dictyostelium, and animal cells 
in general, based simply on the observation that the actin 
content of yeast is 100 times less than that in other cells. In 
most animal cells, the concentration of actin is very high 
(200  ~M) relative to the  critical concentration for poly- 
merization (0.1  p.M), and these cells most likely use actin 
monomer-binding proteins, such as thymosin and profilin, 
to create a buffered pool of actin monomers available for 
rapid  assembly. Yeast, however, have no apparent need 
for  rapid  and  dynamic  actin  assembly.  Although  they 
clearly need to create actin filaments as they grow and di- 
vide, there is no evidence that filaments ever disassemble. 
In addition, there are no reports of a buffered pool of actin 
monomers in yeast, and our experiments here find that the 
soluble monomer pool is indeed very small. Therefore, we 
hypothesize that in yeast actin filaments are inherently un- 
stable due to the low actin concentration and therefore ac- 
tin-binding proteins function to create, assemble, and sta- 
bilize actin filaments. 
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measured actin filament assembly by two complementary 
assays in yeast mutants lacking CP and fimbrin, another 
actin-binding  protein  that  interacts  genetically  with  CP 
and has also been hypothesized to stabilize actin filaments 
(1).  We find that actin filament assembly is decreased  in 
vivo in  these  mutants. We  also searched for actin muta- 
tions that enhance the phenotype of CP mutations, a ge- 
netic interaction similar to the effect of the loss of fimbrin. 
We identified a set of actin mutations that do enhance the 
loss of CP and find that these actin mutations also cause 
decreased actin filament assembly in vivo. To investigate 
the molecular basis for this observation, we purified actin 
from these mutants and found that the mutant actins often 
show either decreased polymerization or poor binding to 
fimbrin in vitro. These  observations also support the hy- 
pothesis  that  CP  and  fimbrin  act  to  stabilize  actin  fila- 
ments. As predicted, these conclusions are the opposite of 
the ones found in Dictyostelium (15). 
Materials and Methods 
Materials, Media, and Culture Conditions 
Unless stated  otherwise,  chemicals, materials  and  solvents were  from 
Fisher Scientific Co. (Pittsburgh, PA) or Sigma Chemical Co. (St. Louis, 
MO).  Restriction  endonucleases and  other  enzymes were  from  Boeh- 
ringer-Mannheim Biochemicals  (Indianapolis,  IN).  Yeast  rich  medium 
(YEPD),  sporulation medium (MSPO)  and synthetic minimal medium 
with different metabolites omitted for selection (DOBA), were from BIO 
101,  Inc.  (La Jolla,  CA).  Medium containing 0.1%  5-fluoroorotic  acid 
(PCR Inc., Gainesville, FL) was prepared as described (16).  Presporula- 
tion medium was YEPD with adenine (200 p.g/ml).  Strains were grown at 
30°C unless specified otherwise. 
Molecular and Genetic Techniques 
Strains used in this work are listed in Table I. Tetrad dissection, random 
spore  analysis, and  yeast LiCI  transformation were  as  described  (16). 
DNA manipulations were performed by standard methods (25). Yeast ge- 
nomic DNA was prepared as described (11). Mutant actl alleles were cy- 
cle sequenced (9) from both PCR-amplified genomic DNA and gap-repair 
plasmids using [,,/33p] ATP to end-label a set of oligonucleotide primers 
that covered the gene. 
Proteins 
Two-dimensional  gel  electrophoresis  and  immunoblotting  were  per- 
formed as described (33), using goat anti-yeast actin antibodies (17). Actin 
was purified as described (18), except that a MonoQ column was substi- 
tuted for the DEAE column. Also, the pool from the MonoQ column was 
further purified by a cycle of polymerization--depolymerization (14). Puri- 
fied wild-type (wt)  and mutant actins showed minimal proteolysis on a 
heavily loaded SDS gel. To exclude contamination or reversion, we also 
sequenced the relevant region of each actl gene by PCR amplification and 
cycle sequencing, using yeast ceils obtained at the end of the preparation 
as template. 
To test actin polymerization, each mutant actin was polymerized at 6 
IxM for 2 h at room temperature in 1 ×  MKEI (2 mM MgCI2, 100 mM KC1, 
1 mM EGTA, 20 mM imidazole/HCl, pH 7.0), then diluted to 3, 1, and 0.5 
IxM in the same buffer and incubated for an additional 2 h. Samples were 
periodically  mixed gently during  the incubation,  to  accelerate  the  ap- 
proach to steady state. 25 of 100 t~1 was removed, for the sample "Total," 
and added to 25 ~1 of 2×  SDS sample buffer. The remaining 75 ixl was 
spun at 150,000 g for 30 rain at 22°C (70,000  rpm in a rotor (TLA 100.1, 
Beckman Instruments, Inc., Fullerton, CA) in a centrifuge (TL100; Beck- 
man Instruments, Inc.)). 25 0,1 was removed from the meniscus, for the 
sample "Supernatant," and added to 25 Ixl of 2x SDS sample buffer. The 
remaining liquid was removed, avoiding the pellet, and the pellet was dis- 
solved in 150 I~1 of 1 × SDS sample buffer. Equal vols of the three samples, 
which represent equivalent fractions of the total sample, were analyzed on 
10% SDS-polyacrylamide gels. 
Yeast fimbrin, Sac6p, was purified as described (14) and kindly pro- 
vided by T. S. Sandrock and A. E. M. Adams (University of Arizona, Tuc- 
son, AZ). Sedimentation assays to determine binding of fimbrin to the 
mutant actins were performed as described (14) with the following modifi- 
cations: (a) the fimbrin (Sac6p) concentration was 0.75 o,M; and (b) sam- 
ples were  sedimented at 90,000 g  for 60 min at 22°C (50,000  rpm in  a 
TLA100.1  rotor  in  a  TL100  centrifuge).  Fimbrin  alone  partially  sedi- 
mented under these conditions, even with prior clarification; therefore, we 
analyzed the fimbrin in the supernatant, comparing each  mutant actin 
with wt actin and no actin. 
For actin polymerization and fimbrin-binding assays, 10% SDS-poly- 
acrylamide gels stained with Coomassie blue were scanned and the inten- 
sity of the relevant bands was quantitated with NIH Image 1.54, (available 
by ftp from zippy.nimh.nih.gov). Intensities of actin bands were converted 
to absolute amounts by comparison with internal standards. 
Cell Actin Assembly Assays 
In each assay, cultures were grown in YPD to 107 cells/ml, and total pro- 
tein was determined by Bradford assay (6) for normalization of the actin 
values. 
To determine total  actin, cells were  completely disrupted with glass 
beads for SDS-PAGE. Actin was measured by a quantitative immunoblot 
using either affinity-purified goat antiyeast actin (17) or the mouse antiac- 
tin mAb C4 (20)  as the first Ab and 125I-labeled  secondary Abs as de- 
scribed (15). Five aliquots of cells were assayed for each strain, with three 
serial twofold dilutions. 
To determine G-actin levels, the amount of soluble actin released from 
Table L Yeast  Strains Used in This Study 
Name  Relevant genotype  Source 
KWY201  MATa/s actl::LEU2/ACTI  ura3/ura3 leu2/leu2 his3/his3 
KTI277 
KT1278 
YJC 450 
YJC 472 
YJC536 
YJC 542 
YJC 960 
YJC 963 
YJC 1080 
YJC 1096 
YJC 1104 
YJC 1107 
YJC 1117 
YJC 1133 
MATa cap2-1::URA3 ura3 Ieu2 his3 
MATa cap2-t::URA3 ura3 leu2 his3 
MATs cap2::HIS3 ade2 ade3 lys2 ura3 leu2 
MATa cap2::HlS3 ade2 ade3 lys2 ura3 leu2 trpl his3 [pBJ 198 - CAP2 ADE3 URA3] 
MATa slcl-66 cap2::H1S3 ade2 ade3 ura3 leu2 trpl [pBJ 198 - CAP2 ADE3 URA3] 
MATa slcl-87 cap2::HlS3 ade2 ade3 ura3 leu2 trpl [pBJ 198 - CAP2 ADE3 URA3] 
MATa/s slcl-66/slc1-66 cap2::HIS3/cap2::H1S3 ade2/ade2 ade3/ade3 ura3/ura3 leu2/leu2 
trp l/TRP1 lys2/LYS2 his3/his3 [pBJ 416 - ADE3 LEU2 CAP2] 
MATa slcl-87 cap2::HIS3 ade2 ade3 ura3 leu2 trpl lys2 [pBJ 414 - CAP2 ADE3 LEU2] 
MATs slcl-87 cap2::LEU2 ade2 ade3 ura3 leu2 trpl [pBJ 198 - CAP2 ADE3 URA3] 
MATa actl-lOl::HIS3 his3 ura3 leu2 tub2 
MATa actl-lO8::H1S3 his3 ura3 leu2 tub2 
MATs act1-113::HlS3 his3 ura3 leu2 tub2 
MATs act1-120::HlS3 his3 ura3 leu2 tub2 
MATa act1-133::HIS3 his3 ura3 leu2 tub2 
K. Wertman, University of 
California, Berkeley 
This study 
This study 
17 
17 
17 
17 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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flash  freezing  and  saponin  treatment  in  an  F-actin  stabilizing  buffer 
MKEI, essentially as described (21). This procedure provides permeabil- 
ity for actin monomers and 70 kD dextran. The permeabilized cells were 
sedimented in a microfuge for 15 min, and the supernatant was removed 
for determination of actin and protein. In wt cells, the actin level was very 
low, therefore the volume loaded onto the gel was maximized. In this ex- 
periment, error was propagated from the error in the determination of ac- 
tin level from the blot and the error in the protein assay. 
To  determine  F-actin  levels  in  fixed cells,  a  rhodamine-phaUoidin- 
binding assay was performed (22).  A  control with unlabeled phalloidin 
(Molecular Probes Inc., Eugene, OR) was performed for each sample to 
determine nonspecific binding. Four aliquots of fixed cells were assayed 
for each strain, with three serial twofold dilutions. 
The level of F-actin could not be determined as the pelletable fraction 
in  the  latter,  permeabilized  cell,  experiment  because  only  a  fraction 
(/>65%) of the cells are permeabilized by this procedure (21). Attempts at 
a  similar  analysis with  a  more  aggressive method of permeabilization 
(bead-beating) gave inconsistent results, presumably due to variable dis- 
ruption of F-actin-containing cell structures. 
Cloning of SLC  llA CT1 
A synthetic lethal screen with cap2A  yielded two alleles, slcl-66 and slcl- 
87 (17), of a gene that we now identify as actl.  Strain YJC 963  carrying 
slcl-87  and  cap2A  and  a  plasmid with  CAP2  was  transformed with  a 
cDNA library under control of the GALl promoter (23), kindly provided 
by Anthony Bretscher (Cornell University, Ithaca, NY) and screened for 
rescue of synthetic lethality by colony color sectoring. The frequency of 
transformation was estimated by plating aliquots on Ura- medium. Ali- 
quots of the transformation, each containing at least 25 transformants, 
were grown in 96-well microtiter plates in -Ura/glucose and then plated 
on  -Ura/galactose.  Approximately  9,000  independent  transformants 
were  screened.  Each  independent transformant was  represented by  at 
least four colonies. After 5 d at 30°C, red/white sectoring was examined, 
and colonies with white sectors, indicating loss of pBJ 414, were tested for 
Leu-, Ura-/glucose, and Ura+/galactose. Plasmids were  recovered  and 
transformed back into the original strain to confirm their ability to rescue. 
Based on restriction endonuclease maps, three different types of plas- 
mids were recovered that complemented slcl. One plasmid type carried 
CAP2, based on Western and Southern analysis and DNA sequence. A 
second plasmid type carried ACTI, based on DNA sequence. Three non- 
identical clones (pBJ 476, 477, and 481) were recovered. A third group of 
plasmids with insert size ~1 kb showed weak rescue on retransformation, 
and DNA sequencing and database searching with BLAST (2) did not 
identify the cDNA. These plasmids were not analyzed further. 
The ACTI plasmids, pBJ 476 and 477, rescued the synthetic lethality of 
both alleles, slcl-66 and slcl-87, upon transformation into strains YJC 960 
and 963, respectively. In addition, a  CEN plasmid carrying ACT1 under 
control of its own promoter (pBJ 508) provided partial rescue of synthetic 
lethality for slcl-87 and complete rescue for slcl-66. 
Overexpression of ACTI  is lethal in some strains, but not in the wt 
background used here or in certain actl strains (23). We suspect that over- 
expression was important for the success of cloning. Several different ge- 
nomic libraries produced no clones that rescued, and ACT1 with its own 
promoter on a CEN plasmid provided only partial rescue for one allele. 
Both alleles were previously observed as semidominant, with slcl-87 more 
so than slcl-66 (17). Therefore, the levels of the rescuing wt Actlp pre- 
sumably needed to be in excess of those of the mutant Actlp. 
Recombinational Allelism Test for slc  l and ACT1 
To determine whether slcl was allelic to ACT1, a recombinational allelism 
test was performed on a heterozygous diploid carrying one copy of slcl-87 
and one copy of ACT1 marked by LEU2. The integrating plasmids pBJ 
486 and 489 contain a promoterless fragment of ACT1 because they were 
constructed from the SalI/NotI inserts of cDNA clones pBJ 476 (1.4 kb) 
and pBJ 477 (1.8 kb), respectively. Integration of pBJ 486 or 489 at the ge- 
nomic locus of ACT1 results in two copies of ACT1, only one of which is 
expressed, pBJ 486 and 489 carry LEU2 as a marker, which was chosen to 
allow detection of plasmid integration at LEU2, instead of at ACT1, by 
testing for linkage to MAT and the centromere. Constructs were verified 
by restriction digestion. 
The strain YJC 542, which carries slcl-87,  cap2,  and a  CAP2  URA3 
plasmid was transformed with the integrating plasmid that had been cut at 
a  unique HindIII  site in ACT1.  As a  control, a  similar plasmid lacking 
ACT1  sequences was used. Stable  transformants were  mated with the 
cap2 strain YJC 450, and the resulting diploids were subjected to tetrad 
analysis.  Segregants were  tested  for  (a)  synthetic  lethality  by  testing 
growth on 5-fluoroorotic acid to lose the CAP2 URA3 plasmid, (b) the 
ACT1  marker LEU2, (c) mating type (MAT), and (d) the centromere- 
linked marker TRPI. These tests permit discrimination between integra- 
tion at ACT1 as opposed to integration at LEU2. 
sic1  was linked to ACT1  at a  distance <0.49 cM,  ~1.43 kbp. Allele 
numbers 66 and 87 have not been used for actl, to our knowledge. We 
now therefore refer to slcl-66 as act1-66 and to slcl-87 as actl-8Z 
Recovery of Mutant Alleles with Gapped Plasmids 
Replicating plasmid pBJ 508,  which carries an EcoRI genomic clone of 
ACT1 in pRS 314 (36), was cut with NdeI to produce a gap that included 
the entire ACT1 coding region plus 460 bp upstream and 300 bp down- 
stream. The remaining arms were 660 and 1,000 bp. The gapped plasmid 
was transformed into strains YJC 536 and 1080.  Two independent plas- 
mids were recovered for actl-66 and three for actl-8Z 
The plasmids were retransformed into the mutant strain to confirm that 
they could not rescue the synthetic lethal phenotype of the mutant. This 
was the case. However, this test does not exclude actl loss-of-function  mu- 
tations that might be incidental to slcl. To show that the plasmids provide 
actl function, they were transformed into an actlA strain. A  plasmid car- 
rying ACT1 (pBJ 505  -  ACT1  URA3 CEN), actl-66 (pBJ 576 -  actl-66 
URA3 CEN), or actl-87 (pBJ 603  -  actl-87 HIS3 CEN) was transformed 
into the diploid KWY 201, which carries one disruption of actl. On tetrad 
analysis, Leu ÷ (actl::LEU2) segregants were recovered for both actl-66 
and actl-87, but only in the presence of the plasmid carrying the mutant 
actin gene. These results indicate that the recovered slcl/actl alleles func- 
tion in the sense of compensating for the disruption of ACT1, and are not 
simply coincidental loss-of-function mutations. 
Screen of act1 Collection for Synthetic Lethality 
with cap2 
A collection of act1 mutants (38) was screened in two ways. First, to reveal 
synthetic lethality, tetrad dissection was performed on diploids heterozy- 
gous for actl alleles marked by adjacent HIS3 integration and for a cap2:: 
URA3 gene disruption. These diploids were prepared by crossing haploid 
actl  segregants derived from Wertman collection diploids to the cap2.': 
URA3 strains KT1277 or KT1278, depending on mating type. Synthetic le- 
thality was revealed by the absence of actl::HIS3 cap2::URA3 segregants. 
This approach also detects weaker actl  cap2  interactions by comparing 
the growth of actl::H!S3 cap2::URA3  segregants with that of single mu- 
tants. 15 four-spored tetrads were dissected onto YPD. After incubation 
for 4-5 d at 24°C, the spore clones were replica plated to medium lacking 
uracil or histidine to score the cap2::URA3 and acH::HIS3  genotypes, re- 
spectively, and also replica plated to YPD and incubated at 15, 24, and 
37°C to score for temperature-sensitive growth. Before replica plating, we 
microscopically examined those spores that had not grown to macroscopic 
colonies to determine whether germination and cell division had occurred. 
Spore viability was generally very good, except in cases of synthetic lethal- 
ity, and in a few cases where the acH allele showed reduced viability (acH- 
132, act1-136). 
Second, because synthetic lethals detected above could be deficient in 
spore germination or logarithmic growth, we determined whether double 
mutants covered with a CAP2 plasmid could lose the plasmid during loga- 
rithmic growth. The actl  haploids above were crossed with strains YJC 
1082 or 1084, depending on mating type, which carried a cap2::LEU2 dis- 
ruption, covered by a CAP2 URA3 plasmid (pBJ 198). Tetrad dissection 
was performed, and all spore types germinated. The ability to lose the 
plasmid was tested by growth on 5-fluoroorotic acid, and cap2::LEU2 and 
acH::HIS3  genotypes were determined by growth on -Leu and -His, re- 
spectively. In this background, spore viability was poor, so data for differ- 
ent ascospores derived from the same diploid were combined, as in a ran- 
dom spore analysis. Note also that stc2, which is synthetic lethal with cap2, 
is segregating in this analysis. The analysis of sic2 is beyond the scope of 
this paper and is not discussed per se; however, the synthetic lethal seg- 
regants are present and identified to allow consideration of the actl cap2 
phenotype. 
Structural Analysis 
The structure of the actin monomer and filament was viewed and ana- 
lyzed with InsightII on an IRIS computer, using subunit coordinates and 
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Figure 1.  Assays of cellular actin in acH, sac6, and cap2 strains. 
(A) Total actin content. The value is the mean and the error bar 
is the standard error. No strain is significantly  different from wt. 
(B) F-actin content by rhodamine-phalloidin binding.  The value 
is the mean of bound rhodamine fluorescence normalized to total 
protein for each strain,  then normalized to wt. The error bar is 
the standard error. Asterisks mark cases where the difference be- 
tween the mutant and wt is statistically  significant  (P <  0.05). (C) 
G-actin content by determination of soluble actin released from 
Table II. Recombinational Allelism Test  for Linkage of slcl-87 
(Foa-) and ACTI::LEU2 
Foa -  and  LEU2 and  LEU2 and 
LEU2  TRP1  MAT 
ACTlplasmids  P  N  T  P  N  T  P  N  T 
pBJ489  11  0  0  1  3  7  2  3  6 
pBJ489  15  0  0  2  2  11  1  2  11 
pBJ486  12  0  0 
pBJ486  13  0  0  2  1  10  0  4  10 
Total  51  0  0  5  6  28  3  9  27 
Control plasmids  P  N  T  P  N  T  P  N  T 
pBJ487  3  2  3  4  2  2  2  1  5 
pBJ487  3  2  7  2  2  8  2  5  5 
Total  6  4  10  6  4  10  4  6  10 
The number of tetrads of different classes derived from independent transformants  is 
listed. P, parental ditype; N, nonparental  ditype; T, tetratype.  The predicted ratio of tet- 
rads for absence of linkage is IP: IN: 4T. x-squared statistical analysis indicates link- 
age (P <  0.05) for slcl-87 (Foa-) and ACTI::LEU2 at <0.49 cM (~1.4 kbp), and no 
linkage (P >  0.05) in any other case. For the control plasmid that lacks  ACT1, integra- 
tion should have occurred at the LEU2 chromosomal locus,  giving linkage to both 
MAT and the centromere (TRP1).  This linkage is observed in the slight deficiency of 
tetratypes,  which is not statistically  significant  due to the number of tetrads examined. 
helical filament parameters provided by Dr. Michael Lorenz (Max Planck 
Institute, Heidelberg, FRG) (24). 
Results 
CP and Fimbrin Promote Actin Filament Assembly 
In Vivo 
Previously,  CP and  fimbrin  mutations  were  found  to  be 
synthetic lethal  (1,  17).  This  enhanced phenotype  is spe- 
cific for this combination; combinations with many other 
actin-binding  protein  mutations  did  not  show  enhance- 
ment (1), and a screen for mutations synthetic lethal with a 
CP null mutation did not uncover other actin-binding pro- 
tein genes (17 and herein).  An hypothesis to explain  this 
observation,  based  on  the  biochemical  properties  of CP 
and fimbrin in vitro, was that both proteins are capable of 
stabilizing actin filaments  in different ways (1).  CP binds 
to barbed ends and prevents subunit loss; fimbrin binds to 
filament  sides  and also should prevent  subunit  loss from 
ends. Therefore, the loss of two proteins both acting to sta- 
bilize  actin filaments  would lead  to a  severe loss of actin 
filaments. 
We tested this hypothesis by determining the level of ac- 
tin filament assembly in yeast strains lacking CP (cap2 mu- 
tants)  or  fimbrin  (sac6  mutants).  We  used  two  comple- 
mentary assays that  have  been  used  extensively in  other 
cell systems. We performed both assays because each has 
certain  advantages  and  disadvantages.  First,  F-actin  was 
measured  by a  rhodamine-phalloidin-binding  assay.  The 
advantage of this assay is that the cells are chemically fixed 
at the outset; therefore, actin structures are preserved dur- 
ing the assay. The disadvantage is the assumption that all 
actin  filaments  bind  rhodamine-phalloidin  equally  well. 
permeabilized cells. Values are actin normalized to total protein 
in the supernatant after permeabilization. Again, asterisks  mark 
cases where the difference between the mutant and wt is statisti- 
cally significant  (P <  0.05). 
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Number of viable segregants 
act1  Ura  Ura  ÷  Ura-  Ura  ÷  Phenotype  No. of tetrads 
allele  His-  His-  His  +  His  +  of Ura÷His  ÷  (PD/TT/NPD) 
wt  Obs  14  10  14  13  wt  2  10  2 
Exp  14  14  14  14 
101  Obs  13  15  15  0  Microscopic colonies*  4  7  3 
Exp  13  15  15  13 
102  Obs  17  11  11  17  wt  1  9  4 
Exp  17  11  11  17 
104  Obs  13  17  17  13  Slight ts  3  11  1 
Exp  13  17  17  13 
105  Obs  16  12  6  13  Small colonies  1  10  3 
Exp  16  12  12  16 
108  Obs  14  14  12  0  Inviable  2  10  2 
Exp  14  14  14  14 
111  Obs  ~  15  13  2  0  Inviable  §  2  9  3 
Exp  15  13  13  15 
113  Obs  14  14  13  0  Inviable  2  10  2 
Exp  14  14  14  14 
115  Obs  7  21  21  9  ts  7  7  1 
Exp  9  21  21  9 
116  Obs  20  8  10  19  ts  2  6  7 
Exp  20  10  10  20 
117  Obs  16  13  14  16  Slightly ts  3  8  4 
Exp  16  14  14  16 
119  Obs  16  12  14  0  Inviable  3  8  4 
Exp  16  14  14  16 
120  Obs  13  l 5  15  0  Microscopic colonies*  1  13  0 
Exp  13  15  15  13 
121  Obs  15  13  12  15  cs and ts  1  11  2 
Exp  15  13  13  15 
122  Obs  13  17  17  13  ts  3  4  1 
Exp  13  17  17  13 
123  Obs  13  13  13  14  wt  2  10  2 
Exp  14  14  14  14 
124  Obs  16  14  13  0  Small colonies*  3  8  4 
Exp  16  14  14  16 
125  Obs  16  12  11  0  Inviable  0  12  2 
Exp  16  12  12  16 
129  Obs  14  15  16  7  Small colonies  5  6  4 
Exp  14  16  16  14 
132  Obs  17  13  8  0  Inviable  ~  0  13  2 
Exp  17  13  13  17 
133  Obs  16  14  13  0  Inviable  3  8  4 
Exp  16  14  14  16 
135  Obs  14  16  16  14  Slight ts  2  12  1 
Exp  14  16  16  14 
136  Obs  11  19  10  0  Inviable  §  4  11  0 
Exp  11  19  19  11 
The total number of observed (Obs) and expected (Exp) viable haploid segregants of each genotype is listed, along with the phenotype of the actl cap2 segregants, and the number 
of different types of tetrads. 
§These act1 alleles had low viability in this experiment, reflected in the number of Ura-His + segregants. Also, these alleles were not synthetic lethal in a test of logarithmic growth 
(Table IV). 
q0 small colonies could not be analyzed for markers. 
*The genotype of the Ura  ÷ His  + segregants was inferred from those of macroscopic colonies that could be tested for markers. The phenotype listed describes how those spores 
were able to grow. 
Actin-binding  proteins  or actin  mutations may influence 
the efficiency  of phalloidin binding.  Second,  G-actin  was 
measured as the amount of actin that was released in a sol- 
uble form from permeabilized cells. The advantage here is 
that the quantitation of the actin by immunoblot is unam- 
biguous, and the disadvantage is that the permeabilization 
procedure  may cause  the  solubilization of some  F-actin. 
We also measured total cell actin by immunoblot, to deter- 
mine whether  changes  in  the  amount of F-  and  G-actin 
were reflective of the total actin pool or independent ef- 
fects. 
Different  results  with  the  two  different  assays  were 
sometimes found and are to be expected. Actin may exist 
in a form detected in both or neither assays. For example, 
some  actin  filaments  may depolymerize rapidly  and be- 
come soluble on permeabilization, so this pool would be 
measured in both assays. An increase in this pool of actin 
would lead to increased G-actin and unchanged F-actin in 
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Alleles and cap2 during Logarithmic Growth 
Foa  +  Foa- 
Allele  Ratio 
of act1  Leu ÷  Leu  Leu +  Leu  *  Foa+Leu+/total 
wt  9  16  8  2  0.26 
4  14  6  5  2  0.52 
101  0  11  14  1  0.00 
102  10  29  6  0  0.22 
104  14  29  11  0  0.26 
105  14  22  11  0  0.30 
108  0  9  10  0  0.00 
111  2  6  4  0  0.17 
113  0  5  5  0  0.00 
115  11  15  10  0  0.31 
116  10  12  4  0  0.38 
117  9  14  4  0  0.33 
119  0  8  9  0  0.00 
120  0  7  6  0  0.00 
12l  l  2  0  2 
122  2  3  3  0 
123  13  15  6  1  0.37 
124  3  10  8  0  0.14 
125  0  6  4  0  0.00 
129  3  8  10  0  0.14 
132  9  9  1  0  0.47 
133  0  8  2  0  0.00 
135  11  13  7  2  0.33 
136  16  15  4  3  0.42 
Predicted results for four segregants, 
considering segregation at the CAP2 and SLC2 loci 
Synthetic lethality 
none  1  2  1  0  0.25 
actl cap2  0  2  2  0  0 
act1 slc2  1  1  0  0  0.5 
actl sic2 and act1 cap2  0  1  1  0  0.0 
The genotype of the diploids used in this analysis was ACT1/actl::H1S3 cap2-Al:: 
LEU2/CAP2 slc2/SLC2 with a plasmid [CAP2 URA3]. Since only act1 segregants are 
relevant for this analysis, only His  + segregants are included in the table. Note that 
sic2, which is synthetic lethal with cap2, is segregating in this analysis and does show 
allele-specific interactions with act1. The analysis of sic2 is beyond the scope of this 
paper and is not discussed per se, however, the synthetic lethal segregants are present 
and identified here by necessity. The key parameter to examine to determine whether 
an actl allele is synthetic lethal with cap2 is the number of Leu ÷ (cap2) Foa ÷ (plasmid 
loss viable) segregants. In the case of synthetic lethality, the number should be zero, In 
the absence of synthetic lethality, the number of Leu  + Foa ÷ segregants should be ei- 
ther one-half or one-quarter  of the total number of segregants,  depending on whether 
the act1 allele is or is not synthetic lethal with sic2, respectively. 
*CAP2 strains should not be Foa-, therefore,  these segregants must have poor growth 
on FOA for some other reason and presumably represent strains with marginal growth 
properties overall. 
¢These strains  had low viability in this experiment, so no ratio is calculated and no 
conclusion drawn. 
the assays. In support of this possibility, permeabilization 
leads to loss of actin cables (21). On the other hand, dena- 
tured and precipitated actin would neither bind rhodamine- 
phalloidin nor be soluble, which would lead to decreased 
F-actin and unchanged G-actin in the assays. Many actin 
and  actin-binding  protein  mutations  have  this  effect  on 
actin. 
Both CP and fimbrin mutants showed less F-actin, more 
G-actin,  and no change in total actin compared  with wt 
(Fig.  1). Therefore,  the results with the two different  as- 
says  are consistent and support the hypothesis that both 
actin-binding  proteins  promote  actin  filament  assembly. 
For CP, this result is especially interesting because it is the 
opposite of the one found in Dictyostelium, where less CP 
Phenotypes  of double mutants 
actl 
allele  Amino acid substitution  act  l cap2  act1 sac6* 
wt  NE  NE 
3  P32L  ND  NE 
4  E259V  NE  NE 
66  M 16I  SynLet  NE 
87  E292K  SynLet  NE 
101  D363A, E264A  SynLet  Mud 
102  K359A, E361A  NE  Mud 
104  K415A, E316A  Mud  NE 
105  E311A, R312A  Mud  NE 
108  R256A, E259A  SynLet  SynLet 
111  D222A, E224A, E226A  Mud  *  ND 
113  R210A, D211A  SynLet  SynLet 
115  E 195A, R 196A  Mud  SynLet 
116  D187A, K191A  Mud  Mud 
117  R183A, D184A  Mud  Mud 
119  R116A, E117A, K118A  SynLet  SynLet 
120  E99A, EI00A  SynLet  NE 
121  E83A, K84A  Mud  SynLet 
122  D80A, D81A  Mud  ND 
123  R68A, E72A  NE  NE 
124  D56A, E57A  Mud  SynLet 
125  K50A, D51A  SynLet  SynLet 
129  R177A, D179A  Mud  SynLet 
132  R37A, R39A  Mud  ND 
133  D24A, D25A  SynLet  Mud 
135  E4A  NE  NE 
136  D2A  Mud  SynLet 
The results in Tables III and IV are compiled and summarized here. 
NE, no effect; Mud, modified phenotype (slow or temperature-sensitive growth); Syn- 
Let, synthetic lethal; ND, nut determined. 
*The data in this column are reproduced  from the work of Holtzman and colleagues 
(13), except for alleles 66 and 87, which were described by us previously (17). 
SLow viability  reduces the significance  of this interpretation. 
led  to more F-actin  (15).  This  difference is possible  be- 
cause CP binding to barbed ends stops both the addition 
and loss of actin subunits. Therefore, in yeast, CP prevents 
the loss of subunits that otherwise occurs from free barbed 
ends, while in Dictyostelium CP prevents the addition  of 
subunits. 
Pool of Actin Monomers in Yeast 
This difference between Dictyostelium  and yeast is most 
likely due to a difference in the level of actin monomers 
available for addition to free barbed ends. We hypothesize 
that the level is low in yeast and high in Dictyostelium.  The 
total actin content of Dictyostelium is ~100 times that of 
yeast, ~10%  vs ~0.1%  of total cell protein  (12,  15,  27, 
confirmed by Fig. 1 A here). About 50% of actin in Dicty- 
ostelium  is soluble, and therefore exists as either free or 
buffered monomers (15). In contrast, we report here that 
very low levels of actin are soluble in yeast. 
The  soluble  actin  released  from  permeabilized  yeast 
cells is normalized in Fig.  1 C  to the level of protein re- 
leased, to account for possible differences in the percent- 
age of cells permeabilized in different strains. However, if 
one normalizes to total protein in a whole-cell extract, sol- 
uble actin is 2 pg/txg of protein in wt cells. The fraction of 
cells permeabilized in the  assay is  i>60%  (21).  Even as- 
suming that only 50%  of cells are permeabilized, then at 
most 4 pg/Ixg is soluble, and the soluble fraction of actin is 
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The actin band of SDS gels stained with Coomassie blue is shown 
for the total sample (T) before sedimentation  and the superna- 
tant (S) and pellet (P) after sedimentation. The experiment was 
performed  at  three  different  total  actin  concentrations,  listed 
across the top. The act1 allele numbers are indicated at left. (B) 
Graphs  of the  concentration  of actin  (p~M) in the  supernatant 
(filled squares) and pellet (open triangles) fractions vs. total actin 
(~M). The intensities of the bands in A were quantified to pro- 
duce these data. The actl allele numbers are indicated at the up- 
per right of each panel. 
at most 4 pg/1.3 ng  =  0.3%.  This value is  160 times less 
than the comparable value of 50% in Dictyostelium. 
Actin Mutations Enhanced by the Loss of CP 
As an alternative approach to investigate the in vivo role 
of CP on actin filament assembly, we tested whether muta- 
tions in actin that are synthetic lethal with the loss of CP, 
as is the fimbrin mutation, would also lead to actin that did 
not polymerize well in vivo. Our hypothesis predicts that 
actin mutants whose phenotype is aggravated by the loss 
of CP should also have less F-actin in vivo. We tested actin 
mutants from two different sources. First, a screen for mu- 
tations synthetic lethal with the loss of CP (cap2) identi- 
fied two alleles of a gene slcl (17), which we here identify 
as  novel  alleles  of act1,  the  gene  for  actin.  Second, we 
screened  existing  act1  mutations,  including  the  alanine- 
scanning collection of Wertman et al. (38). 
slc  l  Is act  l 
Plasmids  carrying ACT1  cDNA's were  recovered by li- 
brary transformation  to  complement the  cap2  slcl  syn- 
thetic  lethal  phenotype. A  recombinational allelism  test 
showed tight linkage between slcl and A CT1 (Table II). 
Sequence of act  l-66 and act  l-87 
To confirm the assignment of slcl as actl and to determine 
the  amino  acid  sequence  of  the  mutant  actins,  we  se- 
quenced  PCR-amplified  genomic  DNA  and  gap-repair 
plasmids carrying the recovered alleles,  actl-66 has a sin- 
gle base change (ATG to ATA in codon 16) that converts 
Met 16 to Ile. act1-87  has a single base change (GAA to 
AAA in codon 292) that converts Glu 292 to Lys. As pre- 
dicted from these amino acid changes, the electrophoretic 
mobility of Actl-87p shifted to a more basic position and 
that of Actl-66p did not change, by two-dimensional gel 
electrophoresis  and  immunoblots  of whole-cell  extracts 
with antiactin (data not shown). 
Existing act  l Mutants 
We also searched for synthetic lethality among the existing 
collection  of viable  acH  alleles.  Synthetic  lethality  was 
tested in two ways. First, tetrad analysis was performed on 
diploids  heterozygous for act1  alleles  and  a  cap2::URA3 
gene disruption (Table III). An act1 allele categorized as 
synthetic lethal in this test may be defective in spore ger- 
mination or outgrowth, but not be  inviable  during loga- 
rithmic  growth.  To  test  this  possibility  and  to  indepen- 
dently  confirm  the  results  from the  tetrad  analysis,  we 
performed  a  plasmid  loss  assay in  growing cells  (Table 
IV). These  results  largely confirm those  of the  first  ap- 
proach. Some alleles are inviable in the first approach and 
viable in the second, as expected. A compilation and sum- 
mary of all the results is presented in Table V. 
Alleles 66, 87, 101, 108, 113, 119, 120, 125, and 133 were 
inviable in combination with cap2.  Spores failed to grow 
into macroscopic colonies, and  microscopic examination 
revealed that most divided only a few times, but 101 and 
120 gave rise to a few hundred cells. Alleles 104, 105, 111, 
115, 116, 117, 121,122, 124, 129, 132, 135, and 136, showed 
some enhancement of their phenotype in the presence of 
the cap2  mutation. They were more temperature  or cold 
sensitive, grew more slowly at the permissive temperature, 
or were  defective in germination,  representing  a  contin- 
uum of effects. Alleles 4,  102, and 123 exhibited no syn- 
thetic phenotype. 
Karpova et al. Actin Filament  Stability in Yeast  1489 Figure 3.  Structural model of actin, indicating location of mutations. (A) Three views of an actin monomer, in red, with the synthetic le- 
thal allele residues indicated in green. The view labeled Front is similar to the one conventionally shown, with the exception that the 
subunit is rotated slightly counterclockwise about an axis perpendicular to the page, placing it in an orientation similar to that seen in 
the filament. (B) A  filament of five subunits, with the subunits having different colors--purple, red, white, blue, and purple again--as 
one proceeds from barbed to pointed end. Again, the synthetic lethal residues are indicated in green. 
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Our hypothesis then predicts that the set of synthetic le- 
thal actin mutants will include ones that have impaired ac- 
tin filament assembly in vivo, as seen for the CP and fim- 
brin  null  mutants.  We  assayed  the  mutants  for  actin 
filament  assembly  in  vivo  by  the  two  complementary 
methods discussed above, independent measurements re- 
flecting F-actin and G-actin. Total actin was not changed 
significantly for any actl  mutant, as also seen for the CP 
and fimbrin mutants. 
For nearly all the actl mutants, in at least one of the as- 
says, we detected a  defect similar to that seen in CP and 
fimbrin mutants: less F-actin or more G-actin. For alleles 
87 and 113 changes in the predicted direction were seen in 
both assays. The predicted effect was seen in one but not 
the other assay for alleles 66,  101,  and  120.  As discussed 
above,  different  results  in  the  two  assays are  not  unex- 
pected. In the F-actin assay, allele 108 was not tested be- 
cause of poor growth, and 133 showed a change in the pre- 
dicted direction,  but without statistical significance. Both 
108 and 133 were normal in the G-actin assay. 
Biochemical and Structural Analysis of  Actin Mutants 
Our  hypothesis  predicts  two  obvious  molecular  mecha- 
nisms to explain defective actin assembly in vivo in these 
actin mutants. The mutant actin could polymerize poorly 
or it might bind fimbrin poorly. To test further our hypoth- 
esis and discriminate between these possibilities, we puri- 
fied  actin  from the  mutants  and  assayed polymerization 
and fimbrin binding in vitro. We hypothesized that these 
tests might also reveal defects in  actin filament function 
not seen in the in vivo assays. In addition, using the struc- 
tural model of the  actin filament, we were able to make 
predictions and correlate results in the biochemical assays 
with the locations of the mutations. 
First, we tested the ability of the mutant actins to poly- 
merize (Fig. 2). Most alleles did show defective polymer- 
ization, manifested by less actin in the pellet and more in 
the  supernatant  in  a  sedimentation assay. Alleles 66,  87, 
113,  and  133  showed substantial  defects. Alleles  108  and 
120 showed mild defects, and 101 was similar to wt. Struc- 
tural  analysis  provided  interesting  correlations  (Fig.  3). 
First,  amino acid  residue  292,  altered  in  allele 87,  which 
shows  a  severe polymerization defect  in  vitro,  is  a  pre- 
dicted contact between actin subunits  along the long axis 
of the filament. 292 lies within 4/~ of residues 45 and 46 of 
an adjacent subunit. Second, in allele 108, two amino acid 
residues are altered (256 and 259), and they lie just above 
the  loop connecting the protofilament strands.  Although 
residues 256 and 259 are not within 6 A, of any other sub- 
unit, they may be important for the structure of that loop. 
Third, the amino acid residues altered in alleles 66 and 113 
occupy  positions  at  or  near  the  cleft  where  nucleotide 
binds, and nucleotide binding has been shown to be impor- 
tant for subunit and filament stability (7, 8). 
Second, we tested the ability of the mutant actins to bind 
fimbrin.  The  binding  site  for fimbrin  on  actin  has  been 
characterized, and allele 120 shows the best agreement to 
the  criteria  (13,  14,  26).  As  expected,  allele  120  also 
showed decreased fimbrin binding here (Fig. 4). Other al- 
leles that change residues at and near the fimbrin-binding 
Figure 4.  Binding  of fimbrin  to actin.  (A) The fimbrin  (Sac6p) 
and actin  bands of SDS  gels stained with  Coomassie blue are 
shown for the total sample (T) before sedimentation and the su- 
pernatant (S) and pellet (P) after sedimentation.  The actl allele 
numbers are given below each panel.  The panel in the bottom 
right is a control without actin. (B) Binding of fimbrin (Sac6p) to 
mutant actins.  The intensities  of the fimbrin bands in A  were 
quantified.  The amount of fimbrin (Sac6p) in the supernatant is 
plotted as a percentage of the total fimbrin. In a control experi- 
ment without actin,  some fimbrin  does sediment,  despite prior 
clarification. 
site are 125,  101,  119,  and possibly 133  (Fig. 4). In our as- 
says of fimbrin binding,  allele 108 was severely impaired, 
and alleles 101,  113,  and 133 showed moderate defects in 
fimbrin binding  (Fig.  4).  The  explanation  for  decreased 
fimbrin binding by alleles 108 and 113,  located outside of 
the  previously defined fimbrin-binding site, might be ei- 
ther long-range allosteric effects, seen with other actin mu- 
tations  (10,  29,  37),  or interaction  of fimbrin with  addi- 
tional sites not revealed in the previous analysis. 
Therefore,  among the  collection  of actin  mutants  are 
some that show poor polymerization, some that show poor 
fimbrin binding, and some that show both. No alleles are 
normal for both properties. As examples of the first case, 
consider alleles 66 and 87. They show poor polymerization 
(Fig.  2  B),  but  they  bind  fimbrin  well  (Fig.  4  B).  This 
makes sense with their localization in the structure (Fig. 3) 
because  they  are  not  at  the  fimbrin-binding  site,  rather 
they are near the nucleotide-binding  site (66)  and a  sub- 
unit-subunit contact site (87). For the second case, allele 
120  polymerizes well (Fig. 2 B) but binds fimbrin poorly 
(Fig. 4  B).  Again, the  structural  location for this  mutant 
make sense. Others have documented well that this region 
is part of the fimbrin-binding site (13, 14, 26), and this site 
would not be expected to affect polymerization, which is 
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polymerization (Fig. 2 B) and fimbrin binding (Fig. 4 B). 
In this  case,  one  might not  have predicted  these  effects 
based  on  the  structural  location.  The  affected region  is 
close  to but not part of the  recognized sites for fimbrin 
binding or subunit contacts. This discrepancy may reflect a 
limitation in the structural analysis or allosteric effects. 
Another possible molecular model to explain synthetic 
lethality is that another actin-binding protein is essential in 
the absence of CP. Mutations in the binding site for such a 
protein might be identified as ones with normal actin as- 
sembly and fimbrin binding in vitro and in vivo. The set of 
actl mutations does not include exactly such a case, how- 
ever, we did observe a broad range of effects in the assays 
and were not always able to include all strains in every as- 
say.  One potential candidate  is slc2, recovered in  a  syn- 
thetic lethal screen with cap2 (17). slc2 is the mannopro- 
tein synthesis gene MNNIO (Dean, N.,  and J. B. Poster, 
manuscript  submitted  for publication,  and  5)  which  en- 
codes  a  protein  with  sequence  similarity  to  galactosyl 
transferase (Karpova, T. S., and J. A. Cooper, unpublished 
results)  (These  sequence  data  are  available  from  Gen- 
Bank under accession number L42540). 
Discussion 
Mechanisms for Actin Assembly 
The most important conclusions from this study are that, 
in yeast, actin filaments are unstable without either of two 
major actin-binding proteins. The loss of either CP or fim- 
brin leads to decreased F-actin and increased G-actin. This 
hypothesis  was proposed  based  on  several observations. 
First, the loss of both CP and fimbrin is lethal. Second, the 
loss of actin is lethal. Third, the filament is presumed to be 
the functional state of actin. Fourth, the biochemical activ- 
ities of CP and fimbrin in vitro have in common the ability 
to stabilize actin filaments, i.e., to prevent depolymeriza- 
tion.  However, the  biochemical activities of CP  also in- 
clude preventing filament assembly by inhibiting growth at 
barbed ends. Therefore, it was uncertain which biochemi- 
cal activity of CP would be relevant in vivo in yeast. 
For CP, this conclusion was supported by additional ex- 
periments in which  mutations in  actin that  are  also syn- 
thetic lethal with the loss of CP were found to have unsta- 
ble actin in vivo. As expected, some of these actin mutants 
bound  fimbrin  poorly,  in  biochemical  experiments  with 
purified proteins. This would be the equivalent of the loss 
of fimbrin. In addition,  biochemical studies  showed that 
some of these mutant actins polymerized poorly on their 
own.  Therefore, the actin mutants are either unstable  in 
their own polymerization or in binding fimbrin, which con- 
tributes to stability. Coupled with the loss of filament sta- 
bility that accompanies the loss of CP, these mutations are 
now lethal because filament stability is severely compro- 
mised. 
Contrasting Yeast and Dictyostelium 
These conclusions in yeast present  a  striking contrast to 
the case in Dictyostelium, where the opposite conclusions 
were reached (15).  In Dictyostelium, the loss of CP leads 
to increased F-actin. There, actin is poised to assemble, and 
CP, by binding to filament barbed ends, prevents growth. 
CP can act in these opposing fashions in the two systems 
because of its biochemical properties. When bound to the 
barbed end, it prevents both the addition and loss of actin 
subunits, preventing the filament from growing or shrink- 
ing, respectively. Which activity is relevant in a given case 
depends on the concentration of free monomers present in 
solution  and  available  for  polymerization.  If  the  actin 
monomer  concentration  is  high,  then  free  barbed  ends 
tend to polymerize and CP prevents filament growth. On 
the other hand, if the actin monomer concentration is low, 
then free barbed ends tend to depolymerize and CP pre- 
vents filament shrinkage.  In agreement with this  predic- 
tion, the actin monomer concentration in Dictyostelium is 
high, and we report here that in yeast it is low. 
The biology of actin in Dictyostelium vs. yeast supports 
these conclusions. Dictyostelium is highly motile, using a 
high concentration of actin filaments as a basis for motil- 
ity. These filaments are probably highly dynamic and re- 
quire local bursts of actin polymerization and depolymer- 
ization for coordinated assembly. Therefore, the requisite 
high concentrations of monomeric actin needed for bursts 
of assemble must be held in check by actin-binding pro- 
teins. Yeast, on the other hand, are not motile and show 
no analogous need for dynamic actin filament assembly. 
While yeast show dramatic rearrangements of the actin cy- 
toskeleton during the cell cycle and in response to certain 
external  stimuli,  there  is  no  evidence  for substantial  in- 
crease or decrease in the total cellular content of actin fila- 
ments during any of these changes. While actin filaments 
are essential for viability of yeast, they are present at com- 
paratively low concentrations and therefore tend not to as- 
sembly spontaneously.  In  this  system,  the  actin-binding 
proteins may not be needed to hold actin polymerization 
in check, but rather to induce and stabilize actin filament 
formation at the proper location and time. 
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